HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

All-Natural Spray Sunscreen Expands Goddess Garden Organics Reach

This article was originally published in The Rose Sheet

Executive Summary

Launching the first all-natural, chemical-free continuous spray sunscreen opened the door to mass retailers for Goddess Garden Organics, which sells organic sun-care products. The product also speaks to some safety and efficacy concerns FDA raised about sunscreens in 2011.

You may also be interested in...



Senators Push FDA For SPF Cap, Spray Sunscreen Review

A group of Senators has sent a letter to FDA Commissioner Margaret Hamburg asking the agency to resolve sunscreen issues that remain in regulatory limbo. Led by Sen. Jack Reed, D-RI, the Senators urge FDA to establish a UV protection cap and thoroughly review spray sunscreens for safety.

FDA Questions Spray Sunscreen Safety, Efficacy & Monograph Status

FDA could exclude increasingly popular spray sunscreens from the final monograph unless firms submit sufficient safety and efficacy data, according to an advanced notice of proposed rulemaking.

J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores

J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018686

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel